Brüderkrankenhaus St. Josef Paderborn
Paderborn, Germany
General hospital in Paderborn, North Rhine-Westphalia
Husener Str. 46, 33098 Paderborn
About Brüderkrankenhaus St. Josef Paderborn
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
German CLL Study Group
4
German High-Grade Non-Hodgkin's Lymphoma Study Group
2
University of Jena
2
AIO-Studien-gGmbH
1
Boston Scientific Corporation
1
Cubist Pharmaceuticals LLC
1
European Society for Blood and Marrow Transplantation
1
Hannover Medical School
1
Ipsen
1
Johannes Gutenberg University Mainz
1
Clinical Trials at Brüderkrankenhaus St. Josef Paderborn
During the past decade, Brüderkrankenhaus St. Josef Paderborn conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on
average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections
2009-06-30
2010-03-11
Completed
129
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
2009-10-01
2021-12-01
Completed
209
Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF)
2001-03-01
2010-11-01
Terminated
205
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study
2012-08-24
2022-05-31
Completed
717
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Brüderkrankenhaus St. Josef Paderborn" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "German CLL Study Group" with 4 trials
sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored, "University of Jena" with 2 trials sponsored and "AIO-Studien-gGmbH"
with 2 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Brüderkrankenhaus St. Josef Paderborn"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "CAPNETZ Stiftung" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were
collaborators in the rest 28 trials.
Clinical Trials Conditions at Brüderkrankenhaus St. Josef Paderborn
According to Clinical.Site data, the most researched conditions in "Brüderkrankenhaus St. Josef Paderborn" are
"Chronic Lymphoid Leukemia" (2 trials), "Chronic Myeloid Leukemia" (2 trials), "Lymphoma" (2 trials), "Advanced or Metastatic Renal Cell Carcinoma" (1 trials) and "Aplastic Anaemia" (1 trials). Many other conditions were trialed in "Brüderkrankenhaus St. Josef Paderborn" in a lesser frequency.
Clinical Trials Intervention Types at Brüderkrankenhaus St. Josef Paderborn
Most popular intervention types in "Brüderkrankenhaus St. Josef Paderborn" are "Drug" (19 trials), "Biological" (5 trials), "Device" (3 trials), "Radiation" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Obinutuzumab" (5 trials), "Atezolizumab" (4 trials), "Rituximab" (3 trials), "Venetoclax" (3 trials) and "Acalabrutinib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Brüderkrankenhaus St. Josef Paderborn
The vast majority of trials in "Brüderkrankenhaus St. Josef Paderborn" are
25 trials for "All" genders.
Clinical Trials Status at Brüderkrankenhaus St. Josef Paderborn
Currently, there are NaN active trials in "Brüderkrankenhaus St. Josef Paderborn".
undefined are not yet recruiting,
6 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Brüderkrankenhaus St. Josef Paderborn,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Brüderkrankenhaus St. Josef Paderborn, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Brüderkrankenhaus St. Josef Paderborn
Brüderkrankenhaus St. Josef Paderborn has several departments that took part in Clinical trials: "Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie und Onkologie" - 2 trials
Departments List
Name
City
Trials